Hollie Franklin, Author at Drugs in Context

Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

Keira A Fieldhouse Bsc, Samantha Ukaibe BSc, Erika L Crowley BSc, MSc, Reena Khanna MD, MSc, FRCPC, Ashley O’Toole MD, MHSc, FRCPC, Melinda J Gooderham MD, MSc, FRCPC

Article Type

Review

Published

21 Apr 2020

This paper reviews all incident cases and exacerbations of IBD reported in the literature during widescale use of IL-17 inhibitors beyond the clinical trials.

Corrigendum: Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experience

Felicia Pantò MD, Liboria Adamo BSc, Carla Giordano MD, Carmelo Licciardello MD

Article Type

Corrigendum

Published

15 Apr 2020

The authors wish to make the following corrections to their article: Pantò F, Adamo L, Giordano C, Licciardello C. Efficacy and safety of photodynamic therapy with RLP068 for diabetic foot ulcers: a review of the literature and clinical experience. Drugs in Context 2020; 9: 2019-10-3. DOI: 10.7573/dic.2019-10-3

Immunotherapy in inoperable stage III non-small cell lung cancer: a review

Natasha A Jain MD, Gregory A Otterson MD

Article Type

Review

Published

17 Jun 2019

This article summarizes the current status and ongoing clinical trials incorporating immunotherapy into the management of inoperable stage III nonsmall cell lung cancer.

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

Federico Lavorini MD, PhD

Article Type

Review

Published

05 Jun 2019

The aim of this article is to provide an overview of the scientific literature on Easyhaler, with the purpose of emphasising features that make it close to the concept of an ‘ideal’ inhaler for daily use in patients with asthma or chronic obstructive pulmonary disease.

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

Fernando Pérez-Ruiz MD, PhD, Tim Jansen MD, Anne-Katrin Tausche MD, Mónica Juárez-Campo BSc, Ravichandra Karra Gurunath MD, Pascal Richette MD, PhD

Article Type

Review

Published

15 May 2019

The review aims to review current evidence about the efficacy and safety of lesinurad in combination with xanthine oxidase inhibitors in the treatment of hyperuricemia in patients with gout.